{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:34:39Z","timestamp":1785411279867,"version":"3.56.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["16-430"],"award-info":[{"award-number":["16-430"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["16-608"],"award-info":[{"award-number":["16-608"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014191","name":"Brain Research New Zealand","doi-asserted-by":"publisher","award":["PDF-3710566"],"award-info":[{"award-number":["PDF-3710566"]}],"id":[{"id":"10.13039\/501100014191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016905","name":"Hugh Green Foundation","doi-asserted-by":"crossref","award":["3712033"],"award-info":[{"award-number":["3712033"]}],"id":[{"id":"10.13039\/100016905","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Research Centre for Growth and Development\/Gravida","award":["MP0903"],"award-info":[{"award-number":["MP0903"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.nbd.2020.105092","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T12:20:20Z","timestamp":1600863620000},"page":"105092","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Inconsistencies in histone acetylation patterns among different HD model systems and HD post-mortem brains"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8713-1470","authenticated-orcid":false,"given":"Pritika","family":"Narayan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma L.","family":"Scotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailsa L.","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasim F.","family":"Mehrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malvindar K.","family":"Singh-Bains","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.M.","family":"Faull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8166-4014","authenticated-orcid":false,"given":"Russell G.","family":"Snell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Dragunow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2020.105092_bb0005","first-page":"137","article-title":"The caudate nucleus undergoes dramatic and unique transcriptional changes in human prodromal Huntington\u2019s disease brain","volume":"12","author":"Agus","year":"2019","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.nbd.2020.105092_bb0010","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.nbd.2004.04.001","article-title":"A cell-based screen for drugs to treat Huntington\u2019s disease","volume":"16","author":"Aiken","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2020.105092_bb0015","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-020-0880-6","article-title":"Single-nucleus RNA-seq identifies Huntington disease astrocyte states","volume":"8","author":"Al-Dalahmah","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.nbd.2020.105092_bb0020","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/hmg\/ddx006","article-title":"High resolution time-course mapping of early transcriptomic, molecular and cellular phenotypes in Huntington\u2019s disease CAG knock-in mice across multiple genetic backgrounds","volume":"26","author":"Ament","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2020.105092_bb0025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1212\/WNL.27.2.193","article-title":"Long-term treatment of juvenile Huntington\u2019s chorea with dipropylacetic acid","volume":"27","author":"Bachman","year":"1977","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2020.105092_bb0030","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.bmcl.2008.11.106","article-title":"Discovery of oxazolo[4,5-b]pyridines and related heterocyclic analogs as novel SIRT1 activators","volume":"19","author":"Bemis","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.nbd.2020.105092_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169054","article-title":"Ubiquitin accumulation on disease associated protein aggregates is correlated with nuclear ubiquitin depletion, histone De-ubiquitination and impaired DNA damage response","volume":"12","author":"Ben Yehuda","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2020.105092_bb0040","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1101\/gad.1632708","article-title":"Global histone acetylation induces functional genomic reorganization at mammalian nuclear pore complexes","volume":"22","author":"Brown","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.nbd.2020.105092_bb0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejphar.2015.03.021","article-title":"Mouse models rarely mimic the transcriptome of human neurodegenerative diseases: a systematic bioinformatics-based critique of preclinical models","volume":"759","author":"Burns","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2020.105092_bb0050","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.neuro.26.010302.081142","article-title":"Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders","volume":"26","author":"Caughey","year":"2003","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2020.105092_bb0055","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1038\/npp.2011.128","article-title":"Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington\u2019s disease","volume":"36","author":"Chiu","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2020.105092_bb0060","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1073\/pnas.0500136102","article-title":"Genomic characterization reveals a simple histone H4 acetylation code","volume":"102","author":"Dion","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.105092_bb0065","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ng0893-387","article-title":"Trinucleotide repeat length instability and age of onset in Huntington\u2019s disease","volume":"4","author":"Duyao","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2020.105092_bb0070","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington\u2019s disease mice","volume":"23","author":"Ferrante","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.105092_bb0075","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/archneur.62.6.995","article-title":"Monozygotic twins discordant for Huntington disease after 7 years","volume":"62","author":"Friedman","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2020.105092_bb0080","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1074\/jbc.M410210200","article-title":"Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington\u2019s disease","volume":"280","author":"Gardian","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2020.105092_bb0085","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cell.2015.07.003","article-title":"Identification of genetic factors that modify clinical onset of Huntington\u2019s Disease","volume":"162","author":"Genetic Modifiers of Huntington\u2019s Disease","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2020.105092_bb0090","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/1531-8257(199903)14:2<320::AID-MDS1018>3.0.CO;2-Z","article-title":"Differential clinical and motor control function in a pair of monozygotic twins with Huntington\u2019s disease","volume":"14","author":"Georgiou","year":"1999","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2020.105092_bb0095","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0306-4522(03)00595-5","article-title":"Delayed onset of Huntington\u2019s disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors","volume":"123","author":"Glass","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2020.105092_bb0100","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nbd.2016.02.004","article-title":"Specific promoter deacetylation of histone H3 is conserved across mouse models of Huntington\u2019s disease in the absence of bulk changes","volume":"89","author":"Guiretti","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2020.105092_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033453","article-title":"Genes are often sheltered from the global histone hyperacetylation induced by HDAC inhibitors","volume":"7","author":"Halsall","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2020.105092_bb0110","doi-asserted-by":"crossref","first-page":"E11293","DOI":"10.1073\/pnas.1711243115","article-title":"Brain urea increase is an early Huntington\u2019s disease pathogenic event observed in a prodromal transgenic sheep model and HD cases","volume":"114","author":"Handley","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.105092_bb0115","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0006-291X(02)00498-9","article-title":"Ultrastructure of nuclear aggregates formed by expressing an expanded polyglutamine","volume":"294","author":"Hazeki","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2020.105092_bb0120","doi-asserted-by":"crossref","first-page":"9925","DOI":"10.1038\/s41598-018-28185-4","article-title":"Early alteration of epigenetic-related transcription in Huntington\u2019s disease mouse models","volume":"8","author":"Herv\u00e1s-Corpi\u00f3n","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2020.105092_bb0125","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington\u2019s disease","volume":"100","author":"Hockly","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.105092_bb0130","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington\u2019s disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2020.105092_bb0135","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/mds.21632","article-title":"Sodium phenylbutyrate in Huntington\u2019s disease: a dose-finding study","volume":"22","author":"Hogarth","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2020.105092_bb0140","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3233\/JHD-130067","article-title":"Further molecular characterisation of the OVT73 transgenic sheep model of Huntington\u2019s disease identifies cortical aggregates","volume":"2","author":"Huntington\u2019s Disease Sheep Collaborative Research","year":"2013","journal-title":"J Huntingtons Dis."},{"key":"10.1016\/j.nbd.2020.105092_bb0145","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00001756-200303240-00007","article-title":"Inducible PC12 cell model of Huntington\u2019s disease shows toxicity and decreased histone acetylation","volume":"14","author":"Igarashi","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.nbd.2020.105092_bb0150","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/hmg\/ddq063","article-title":"An ovine transgenic Huntington\u2019s disease model","volume":"19","author":"Jacobsen","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2020.105092_bb0155","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.nbd.2006.04.011","article-title":"Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin","volume":"23","author":"Jiang","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2020.105092_bb0160","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/NEN.0b013e3181d6c436","article-title":"Partial depletion of CREB-binding protein reduces life expectancy in a mouse model of Huntington disease","volume":"69","author":"Klevytska","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2020.105092_bb0165","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1531-8249(199912)46:6<842::AID-ANA6>3.0.CO;2-O","article-title":"Huntington aggregates may not predict neuronal death in Huntington\u2019s disease","volume":"46","author":"Kuemmerle","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2020.105092_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143563","article-title":"RNA sequence analysis of human Huntington Disease brain reveals an extensive increase in inflammatory and developmental gene expression","volume":"10","author":"Labadorf","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2020.105092_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2017.00430","article-title":"Evidence for a pan-neurodegenerative disease response in Huntington\u2019s and Parkinson\u2019s disease expression profiles","volume":"10","author":"Labadorf","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2020.105092_bb0180","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2006.11.013","article-title":"Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha","volume":"127","author":"Lagouge","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2020.105092_bb0185","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1136\/bmj.2.6044.1107-a","article-title":"Sodium valproate in chorea","volume":"2","author":"Lenman","year":"1976","journal-title":"Br. Med. J."},{"key":"10.1016\/j.nbd.2020.105092_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024620","article-title":"D-beta-hydroxybutyrate is protective in mouse models of Huntington\u2019s disease","volume":"6","author":"Lim","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2020.105092_bb0195","doi-asserted-by":"crossref","first-page":"7927","DOI":"10.1073\/pnas.1002924107","article-title":"SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis","volume":"107","author":"Luthi-Carter","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.105092_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041423","article-title":"Genome-wide histone acetylation is altered in a transgenic mouse model of Huntington\u2019s disease","volume":"7","author":"McFarland","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2020.105092_bb0205","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neuropharm.2016.12.021","article-title":"Varenicline improves motor and cognitive deficits and decreases depressive-like behaviour in late-stage YAC128 mice","volume":"116","author":"McGregor","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2020.105092_bb0210","first-page":"2893","article-title":"RNA-Seq of Huntington\u2019s disease patient myeloid cells reveals innate transcriptional dysregulation associated with proinflammatory pathway activation","volume":"25","author":"Miller","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2020.105092_bb0215","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1093\/hmg\/ddu047","article-title":"Early and progressive circadian abnormalities in Huntington\u2019s disease sheep are unmasked by social environment","volume":"23","author":"Morton","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2020.105092_bb0220","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S1474-4422(17)30161-8","article-title":"Identification of genetic variants associated with Huntington\u2019s disease progression: a genome-wide association study","volume":"16","author":"Moss","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2020.105092_bb0225","doi-asserted-by":"crossref","first-page":"7841","DOI":"10.1073\/pnas.140202897","article-title":"Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils","volume":"97","author":"Muchowski","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.105092_bb0230","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jneumeth.2010.08.032","article-title":"High content analysis of histone acetylation in human cells and tissues","volume":"193","author":"Narayan","year":"2010","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2020.105092_bb0235","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jneumeth.2015.03.017","article-title":"Assessing fibrinogen extravasation into Alzheimer\u2019s disease brain using high-content screening of brain tissue microarrays","volume":"247","author":"Narayan","year":"2015","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2020.105092_bb0240","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.nbd.2014.11.023","article-title":"Increased acetyl and total histone levels in post-mortem Alzheimer\u2019s disease brain","volume":"74","author":"Narayan","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2020.105092_bb0245","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","article-title":"Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity","volume":"291","author":"Nucifora","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.nbd.2020.105092_bb0250","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1523\/JNEUROSCI.3493-03.2004","article-title":"CRE-mediated transcription is increased in Huntington\u2019s Disease transgenic mice","volume":"24","author":"Obrietan","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.105092_bb0255","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1093\/hmg\/ddn273","article-title":"Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington\u2019s disease","volume":"17","author":"Pallos","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2020.105092_bb0260","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington\u2019s disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2020.105092_bb0265","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/ng1534","article-title":"Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons","volume":"37","author":"Parker","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2020.105092_bb0270","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1001\/archneur.1977.00500170062012","article-title":"Valproate sodium in Huntington chorea","volume":"34","author":"Pearce","year":"1977","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2020.105092_bb0275","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.neuroscience.2005.02.029","article-title":"Activating transcription factor 2 expression in the adult human brain: association with both neurodegeneration and neurogenesis","volume":"133","author":"Pearson","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2020.105092_bb0280","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/hmg\/dds037","article-title":"Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice","volume":"21","author":"Pouladi","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2020.105092_bb0285","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0168-9525(01)02625-7","article-title":"Lessons from animal models of Huntington\u2019s disease","volume":"18","author":"Rubinsztein","year":"2002","journal-title":"Trends Genet."},{"key":"10.1016\/j.nbd.2020.105092_bb0290","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-018-0277-1","article-title":"PU.1 regulates Alzheimer's disease-associated genes in primary human microglia","volume":"13","author":"Rustenhoven","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2020.105092_bb0295","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ncpneuro0199","article-title":"Mechanisms of disease: histone modifications in Huntington\u2019s disease","volume":"2","author":"Sadri-Vakili","year":"2006","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.nbd.2020.105092_bb0300","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/hmg\/ddm078","article-title":"Histones associated with downregulated genes are hypo-acetylated in Huntington\u2019s disease models","volume":"16","author":"Sadri-Vakili","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2020.105092_bb0305","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2377-6-11","article-title":"Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series","volume":"6","author":"Saft","year":"2006","journal-title":"BMC Neurol."},{"key":"10.1016\/j.nbd.2020.105092_bb0310","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","article-title":"Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions","volume":"95","author":"Saudou","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2020.105092_bb0315","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jneumeth.2008.02.007","article-title":"High throughput quantification of mutant huntingtin aggregates","volume":"171","author":"Scotter","year":"2008","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2020.105092_bb0320","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1476-5381.2010.00773.x","article-title":"Neuroprotective potential of CB1 receptor agonists in an in vitro model of Huntington\u2019s disease","volume":"160","author":"Scotter","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2020.105092_bb0325","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1212\/WNL.26.1.61","article-title":"Huntington\u2019s disease: treatment with dipropylacetic acid and gamma-aminobutyric acid","volume":"26","author":"Shoulson","year":"1976","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2020.105092_bb0330","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2020.105092_bb0335","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1111\/j.0953-816X.2004.03374.x","article-title":"Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6\/1 Huntington\u2019s disease transgenic mice","volume":"19","author":"Spires","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2020.105092_bb0340","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/hmg\/ddm064","article-title":"Modulation of nucleosome dynamics in Huntington\u2019s disease","volume":"16","author":"Stack","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2020.105092_bb0345","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","article-title":"The Huntington\u2019s disease protein interacts with p53 and CREB-binding protein and represses transcription","volume":"97","author":"Steffan","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.105092_bb0350","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila","volume":"413","author":"Steffan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2020.105092_bb0355","doi-asserted-by":"crossref","first-page":"7999","DOI":"10.1073\/pnas.95.14.7999","article-title":"High level transactivation by a modified Bombyx ecdysone receptor in mammalian cells without exogenous retinoid X receptor","volume":"95","author":"Suhr","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.105092_bb0360","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1176\/ajp.135.3.352","article-title":"Sodium valproate in Huntington\u2019s disease","volume":"135","author":"Symington","year":"1978","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.nbd.2020.105092_bb0365","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0303-8467(76)80007-8","article-title":"Sodium valproate in Huntington\u2019s chorea","volume":"79","author":"Tan","year":"1976","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.nbd.2020.105092_bb0370","doi-asserted-by":"crossref","first-page":"15564","DOI":"10.1073\/pnas.0804249105","article-title":"The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington\u2019s disease transgenic mice","volume":"105","author":"Thomas","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.105092_bb0375","first-page":"107","article-title":"Neuroprotection and brain cholesterol biosynthesis in Huntington's disease","author":"Valenza","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.105092_bb0380","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12035-014-8715-8","article-title":"Transcription, epigenetics and ameliorative strategies in Huntington\u2019s Disease: a genome-wide perspective","volume":"51","author":"Valor","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2020.105092_bb0385","doi-asserted-by":"crossref","first-page":"10471","DOI":"10.1523\/JNEUROSCI.0670-13.2013","article-title":"Genomic landscape of transcriptional and epigenetic dysregulation in early onset polyglutamine disease","volume":"33","author":"Valor","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.105092_bb0390","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/j.1460-2075.1996.tb00608.x","article-title":"Acetylation of histone H4 plays a primary role in enhancing transcription factor binding to nucleosomal DNA in vitro","volume":"15","author":"Vettese-Dadey","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2020.105092_bb0395","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1038\/nprot.2006.354","article-title":"Immunohistochemical staining of post-mortem adult human brain sections","volume":"1","author":"Waldvogel","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.nbd.2020.105092_bb0400","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1073\/pnas.0308679101","article-title":"Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington\u2019s disease age of onset","volume":"101","author":"Wexler","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.105092_bb0405","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.brainres.2013.02.012","article-title":"Histone deacetylase class II and acetylated core histone immunohistochemistry in human brains with Huntington\u2019s disease","volume":"1504","author":"Yeh","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2020.105092_bb0410","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/hmg\/11.8.905","article-title":"Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice","volume":"11","author":"Yu","year":"2002","journal-title":"Hum. Mol. Genet."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120303673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120303673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:21:41Z","timestamp":1760851301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996120303673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":82,"alternative-id":["S0969996120303673"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2020.105092","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inconsistencies in histone acetylation patterns among different HD model systems and HD post-mortem brains","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2020.105092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105092"}}